You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Immunoassay for diagnosis of Babesia infection

    SBC: IMMUNETICS, INC.            Topic: R

    DESCRIPTION provided by applicant In this Phase II project development and clinical validation of an ELISA test for in vitro diagnosis of Babesia microti infection will be completed Babesiosis is an emerging tick borne parasitic disease which may cause severe to fatal illness in immunocompromised or otherwise weakened patients and may be carried in the blood subclinically in up to of the ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  2. Babesia antigen detection assay for blood screening

    SBC: IMMUNETICS, INC.            Topic: NHLBI

    DESCRIPTION provided by applicant Human babesiosis is a malaria like illness caused by infection of red blood cells by the protozoan parasite Babesia microti or related species primarily transmitted to humans through the bite of infected deer ticks Babesiosis can also be transmitted by blood transfusion and is currently acknowledged as the foremost unaddressed infectious risk to the US blood ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  3. IGF OT IGF SBIR TOPIC DIRECT TO PHASE II CLOSURE DEVICES FOR TRANSCAVAL ACCESS TO THE ABDOMINAL AORTA

    SBC: TRANSMURAL SYSTEMS LLC            Topic: NHLBI

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  4. Antibiotics for Recalcitrant Infection

    SBC: ARIETIS CORPORATION            Topic: R

    DESCRIPTION provided by applicant The goal of the project is to develop a therapeutic capable of sterilizing recalcitrant chronic infections such as deep seated abscess osteomyelitis endocarditis and biofilms of indwelling devices Many of these infections are essentially untreatable and lead to substantial morbidity and mortality In many cases recalcitrance of an infection is not caused b ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  5. GhostSwimmer: Tactically Relevant, Biomimetically Inspired, Silent, Highly Efficient and Maneuverable Autonomous Fish Robot

    SBC: BOSTON ENGINEERING CORPORATION            Topic: N08T030

    Boston Engineerings proposed project significantly increases the Navys capabilities by providing a technology that performs superbly in tactically critical littoral and VSW applications currently unaddressed. We propose to advance the existing technology readiness level (TRL) by combining our GhostSwimmer AUV with actuation, sensing, payload, and processing technology as applicable. Our proposed p ...

    SBIR Phase II 2015 Department of DefenseNavy
  6. Molecular Detection of Invasive Fungal Infections

    SBC: IMMUNETICS, INC.            Topic: R

    DESCRIPTION provided by applicant The incidence of invasive fungal infections and in particular Candida infections the fourth most common nosocomial pathogen has continued to increase over the past years This increase is due to the increasing numbers of patients subjected to severe immunosuppression as a result of transplant procedures chemotherapy regimens advances in medical and sur ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  7. Multi-Function Mid-Wave/Long Wave Infrared Laser

    SBC: FORWARD PHOTONICS LLC            Topic: N131042

    TeraDiode is developing a low Size, Weight, and Power (SWAP) multi-band MWIR/LWIR laser module for NAVSEA under SBIR funding. TeraDiode is employing high power Quantum Cascade Laser (QCL) bars in this laser module and WBC to combine the multiple wavelengths. The laser module is very compact and has three wavelength bands in the MWIR and LWIR as well as high power per band (>10 W per band average p ...

    SBIR Phase II 2015 Department of DefenseNavy
  8. Optimization of novel pyranopyridine efflux pump inhibitors

    SBC: MICROBIOTIX, INC.            Topic: NIAID

    DESCRIPTION provided by applicant Multi drug resistance MDR in Gram negative pathogens including the Enterobacteriaceae and Pseudomonas aeruginosa poses a significant threat to our ability to effectively treat infections caused by these organisms A major component in the development of the MDR phenotype in Gram negative bacteria is overexpression of RND type efflux pumps which actively pu ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  9. Novel technologies to remove obscuring blood from fine needle aspiration biopsies

    SBC: AFFINERGY, LLC            Topic: NIGMS

    SUMMARY ABSTRACT Fine needle aspirationFNAcytology is the standard technique for evaluating thyroid nodulesHemorrhaging is common during the procedurehoweverleading to an aspirate that is significantly diluted by bloodSubsequent slide preparations are often suboptimalresulting in nondiagnostic outcomes that necessitate additional testing or diagnostic surgeryIn factquality is so unpredictable that ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  10. Novel commensal polysaccharide treats multiple sclerosis through Treg modulation

    SBC: SYMBIOTIX BIOTHERAPIES, INC.            Topic: NIAID

    DESCRIPTION provided by applicant Multiple sclerosis MS is a chronic demyelinating inflammatory disease that is the most common neurological disease of young adults affecting over patients in the US and over million patients worldwide MS is a disease of high unmet medical need currently treatable with one of twelve FDA approved drugs all of which result in either significant i ...

    STTR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government